No news is good news. The EMA process continues. There was no withdrawal of Blarcasemine. The wait goes on. There’s always next month. I expect CHMP positive recommendation at the November meeting with EMA approval early 2026. Unfortunately it gives shorts more time to play with the share price. Still time to sell out of the $ covered calls short term and buy Jan 2027 calls.
Market Data 
Markets 
AI
